Silverlon's New Wound Care Website Gives Surgeons, Healthcare Professionals Searchable Access to Clinical Studies and Silverlon Products by Specialty
Website offers one-stop resource on science of silver in infection prevention across specialties -surgical, wound care, burn, catheter and negative pressure contact dressings - including instructional videos
GENEVA, Ill., Nov. 8, 2018 /PRNewswire-PRWeb/ -- Argentum Medical, LLC and Cura Surgical launched its new website for its Silverlon® antimicrobial wound care technology (https://www.silverlon.com). The robust website gives surgeons and other healthcare professionals — both in civilian and in military settings — convenient access to the science and clinical research supporting the most evidence-based silver-based dressings available today.
Users of the new Silverlon website can quickly find Silverlon wound care products by specialty, including surgical, wound care, burn, catheter and negative pressure contact dressings. The site includes educational videos to explain the antimicrobial advantage of silver ions as well as instructional videos on the proper use of Silverlon dressings in a number of clinical settings.
The website also features a searchable index of independent, peer-reviewed, clinical studies that demonstrate the effectiveness of Silverlon technology across multiple specialties including surgical, venous catheter, wound and burn care. Recent clinical studies include research conducted by the Harvard Combined Orthopaedic Residency Program published in the Journal of the American Academy of Orthopaedic Surgeons and the University of South Florida/Tampa General Hospital's central line catheter-related infection (CLABSI) study published in the Journal of Intensive Care Medicine.
"Our new website is designed to give surgeons and other medical professionals an efficient resource to explore the science and robust body of clinical research supporting the advantages of Silverlon dressings as part of a comprehensive infection prevention bundle," said Raul Brizuela, president and CEO of Cura Surgical and Argentum Medical, the company that pioneered Silverlon wound care technology.
Silverlon products use a unique silver-plating process that employs more pure metallic silver than any other silver-based dressing — typically up to 100 times more than the leading impregnated dressings and five times more than crystalline silver dressings1. Silverlon produces a broad-spectrum antimicrobial effect that rapidly kills microorganisms, eradicating Methicillin-resistant Staphylococcus aureus (MRSA) in as little as four hours and Pseudomonas in less than two hours. The sustained release of silver ions in the dressing results in antimicrobial activity that remains effective for up to seven days1.
In addition, the new Silverlon website includes Frequently Asked Questions, a calendar showing Silverlon participation in medical conferences and industry events, and a Newsroom to highlight Silverlon-related developments, including new research, products, partnerships and staff.
About Silverlon
Silverlon® wound dressings have a permanently plated metallic surface, which provides the antimicrobial benefits of silver in the dressing without staining the skin and without increasing bioburden. Silverlon was originally developed for the U.S. military, where it is still extensively used for management of burn and blast injuries. Silverlon dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds. For more, visit http://www.silverlon.com.
Silverlon® Dressings should not be used on patients with 3rd degree burns or with known sensitivity to silver or nylon. For complete Instructions for Use and indicators, please visit:
https://www.silverlon.com/resources/instructions-for-use.
About Argentum Medical
Argentum Medical pioneered the use of silver-plated nylon. Specializing in the development of innovative products made from silver-plated nylon, the company continues to explore new applications and markets for its Silverlon® technology in keeping with its corporate mission to improve clinical outcomes.
1Data on File.
###
SOURCE Silverlon
Share this article